Skip to NavigationSkip to content

Pharmafile - Medical Communications News

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ IL-17A...
Another study has shown hydroxychloroquine is ineffective in treating the coronavirus.
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they...
Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options that could yield pay outs of...
AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of hospitalisation risk...
The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential vaccinations...
The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat.
The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients.
The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it's the first country to complete a vaccine trial...
New reports have suggested that the healthcare sector is embracing digital transformation and accelerating this development in their companies to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches